Advertisement
Screener

Q32 Bio Inc. (FIXX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

1.8 / 5 stars · 13/36 Roast Me

Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $600.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2023-03-09

  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-12-31 was $0.00.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-09-30 was $0.00.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-06-30 was $0.00.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-03-31 was $600.00K, a 0.00% change year-over-year.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $600.00K, a 0.00% change from fiscal 2021.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $600.00K, a 0.00% change from fiscal 2020.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $600.00K, a 68.42% decline from fiscal 2019.
  • Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $1.90M, a 5.56% increase from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$0.00
derived: sum of 2 quarters · filed 2023-03-09
$0.00
derived: sum of 3 quarters · filed 2023-03-09
$600.00K
10-K · filed 2023-03-09
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$600.00K
10-Q · filed 2022-11-10
$600.00K
derived: sum of 4 quarters · filed 2023-03-09
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$600.00K
10-Q · filed 2022-08-15
$600.00K
derived: sum of 3 quarters · filed 2023-03-09
$600.00K
derived: sum of 4 quarters · filed 2023-03-09
2022-03-31$600.00K
10-Q · filed 2022-05-16
$600.00K
derived: sum of 2 quarters · filed 2023-03-09
$600.00K
derived: sum of 3 quarters · filed 2023-03-09
$600.00K
derived: sum of 4 quarters · filed 2023-03-09
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$0.00
derived: sum of 2 quarters · filed 2023-03-09
$0.00
derived: sum of 3 quarters · filed 2023-03-09
$600.00K
10-K · filed 2023-03-09
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$600.00K
10-Q · filed 2022-11-10
$700.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$600.00K
10-Q · filed 2022-08-15
$700.00K
derived: sum of 3 quarters · filed 2022-08-15
$700.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$600.00K
10-Q · filed 2022-05-16
$700.00K
derived: sum of 2 quarters · filed 2022-05-16
$700.00K
derived: sum of 3 quarters · filed 2022-05-16
$700.00K
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
$100.00K
derived: sum of 2 quarters · filed 2022-03-23
$100.00K
derived: sum of 3 quarters · filed 2022-03-23
$600.00K
10-K · filed 2022-03-23
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$0.00
derived: sum of 2 quarters · filed 2021-11-15
$500.00K
10-Q · filed 2021-11-15
$1.00M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$500.00K
10-Q · filed 2021-08-12
$1.00M
derived: sum of 3 quarters · filed 2021-08-12
$1.80M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$500.00K
10-Q · filed 2021-05-06
$1.00M
derived: sum of 2 quarters · filed 2021-05-06
$1.80M
derived: sum of 3 quarters · filed 2021-05-06
$2.00M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$1.30M
derived: sum of 2 quarters · filed 2021-03-11
$1.50M
derived: sum of 3 quarters · filed 2021-03-11
$1.90M
10-K · filed 2021-03-11
2019-09-30$800.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.00M
derived: sum of 2 quarters · filed 2020-11-09
$1.40M
10-Q · filed 2020-11-09
$1.60M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$600.00K
10-Q · filed 2020-08-10
$800.00K
derived: sum of 3 quarters · filed 2020-08-10
$1.40M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$400.00K
10-Q · filed 2020-05-07
$600.00K
derived: sum of 2 quarters · filed 2020-05-07
$1.20M
derived: sum of 3 quarters · filed 2020-05-07
$1.80M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$800.00K
derived: sum of 2 quarters · filed 2020-03-12
$1.40M
derived: sum of 3 quarters · filed 2020-03-12
$1.80M
10-K · filed 2020-03-12
2018-09-30$600.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.20M
derived: sum of 2 quarters · filed 2019-11-12
$1.60M
10-Q · filed 2019-11-12
2018-06-30$600.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$1.00M
10-Q · filed 2019-08-08
2018-03-31$400.00K
10-Q · filed 2019-05-13
$391.91K
10-Q · filed 2018-05-14